Perrigo Company plc (NYSE: PRGO) today announced that its Board of Directors approved a plan to separate the Company's Prescription ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE